EUVIMEDEUVIMED entdecken
Crossref

Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020.

Federico Giannoni, Alessio Lanni, Angelo Iacobino, Lanfranco Fattorini, Italian Multicentre Study on Nontuberculous Mycobacteria (IMS-NTM), members of the IMS-NTM laboratory network

Annali dell Istituto Superiore di Sanità · 21.06.2023 · 59 (2) · 132-138

DOI: 10.4415/ann_23_02_06 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annali dell Istituto Superiore di Sanità, erschienen am 21.06.2023. Verfasst von Federico Giannoni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento Malattie Infettive, Istituto Superiore di Sanità, Rome, Italy. Hauptthemen laut MEDLINE: Nontuberculous Mycobacteria, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Nontuberculous mycobacteria (NTM) are environmental mycobacteria which may cause pulmonary and extrapulmonary diseases. These organisms are difficult to treat due to their intrinsic drug-resistance. In Italy, no major nationwide study on NTM epidemiology and drug susceptibility was performed. METHODS: Data on the epidemiology of 7,469 NTM clinical isolates identified in Italy in 2016-2020 and on the minimum inhibitory concentrations (MICs) of 1,506 of these strains were analysed. RESULTS: Overall, 63 species were identified in 42 hospital laboratories located in 16 out of 20 regions, with Mycobacterium avium complex (MAC) being the most frequently isolated, followed by M. gordonae, M. xenopi, M. abscessus. The MICs of 12 drugs for MAC, M. xenopi, M. kansasii, M. abscessus, M. fortuitum and M. chelonae were interpreted for clinical significance (susceptible, intermediate, resistant) based on the guidelines published by the Clinical and Laboratory Standards Institute in November 2018. CONCLUSIONS: Our data are in line with other nationwide studies and may be of value for further update of microbiological and clinical guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nontuberculous MycobacteriaMycobacterium Infections, NontuberculousHumansMicrobial Sensitivity TestsItaly

Autor:innen und Institutionen

  • Dipartimento Malattie Infettive, Istituto Superiore di Sanità, Rome, Italy.

Zitieren

APA

Giannoni, F., Lanni, A., Iacobino, A., Fattorini, L., Italian Multicentre Study on Nontuberculous Mycobacteria (IMS-NTM), & members of the IMS-NTM laboratory network (2023). Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020. Annali dell Istituto Superiore di Sanità, 59(2), 132-138. https://doi.org/10.4415/ann_23_02_06

Vancouver

Giannoni F, Lanni A, Iacobino A, Fattorini L, Italian Multicentre Study on Nontuberculous Mycobacteria (IMS-NTM), members of the IMS-NTM laboratory network. Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020. Annali dell Istituto Superiore di Sanità. 2023;59(2):132-138. doi:10.4415/ann_23_02_06

BibTeX
@article{Giannoni2023,
  author = {Giannoni, Federico and Lanni, Alessio and Iacobino, Angelo and Fattorini, Lanfranco and Italian Multicentre Study on Nontuberculous Mycobacteria (IMS-NTM), Italian Multicentre Study on Nontuberculous Mycobacteria (IMS-NTM) and members of the IMS-NTM laboratory network, members of the IMS-NTM laboratory network},
  title = {Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020},
  journal = {Annali dell Istituto Superiore di Sanità},
  year = {2023},
  volume = {59},
  number = {2},
  pages = {132--138},
  doi = {10.4415/ann_23_02_06}
}
Kostenlos starten →